641 related articles for article (PubMed ID: 30578107)
41. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
[TBL] [Abstract][Full Text] [Related]
42. Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
Naymagon L; Tremblay D; Zubizarreta N; Moshier E; Mascarenhas J; Schiano T
Dig Dis Sci; 2021 Oct; 66(10):3619-3629. PubMed ID: 33151401
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and Safety of Nadroparin Calcium-Warfarin Sequential Anticoagulation in Portal Vein Thrombosis in Cirrhotic Patients: A Randomized Controlled Trial.
Zhou T; Sun X; Zhou T; Li Y; Chen X; Cheng B; Gao Y
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00228. PubMed ID: 32858573
[TBL] [Abstract][Full Text] [Related]
44. Transient portal vein thrombosis in liver cirrhosis.
Qi X; Guo X; Yoshida EM; Méndez-Sánchez N; De Stefano V; Tacke F; Mancuso A; Sugawara Y; Yang SS; Teschke R; Arora A; Valla DC
BMC Med; 2018 Jun; 16(1):83. PubMed ID: 29871683
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic anticoagulation after liver transplantation is not useful among patients with pre-transplant Yerdel-grade I/II portal vein thrombosis: A two-center retrospective study.
Bos I; Blondeau M; Wouters D; Camus C; Houssel-Debry P; van der Plas WS; Nieuwenhuis LM; Bardou-Jacquet E; Lisman T; de Meijer VE; Porte RJ; Rayar M
J Thromb Haemost; 2021 Nov; 19(11):2760-2771. PubMed ID: 34297481
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
[TBL] [Abstract][Full Text] [Related]
47. Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban.
Yang H; Kim SR; Song MJ
Clin Mol Hepatol; 2016 Dec; 22(4):499-502. PubMed ID: 27880998
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
[TBL] [Abstract][Full Text] [Related]
49. Utility of Oral Anticoagulants as Prophylaxis of Recurrent Portal Thrombosis after Liver Transplantation.
Sanchez-Ocaña R; Tejedor-Tejada J; Cimavilla-Roman M; de Benito-Sanz M; Asensio-Diaz E; Barrera-Rebollo A; Perez-Saborido B; Garcia-Pajares F; Almohalla-Alvarez C; Sanchez-Antolin G
Transplant Proc; 2019; 51(1):83-86. PubMed ID: 30655140
[TBL] [Abstract][Full Text] [Related]
50. [Diagnosis and treatment of portal thrombosis in liver cirrhosis].
Seijo S; García-Criado A; Darnell A; García-Pagán JC
Gastroenterol Hepatol; 2012 Nov; 35(9):660-6. PubMed ID: 22534116
[TBL] [Abstract][Full Text] [Related]
51. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
[TBL] [Abstract][Full Text] [Related]
52. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis.
Senzolo M; Piano S; Shalaby S; Tonon M; Tonello S; Zanetto A; Sacerdoti D; Simioni P; Bombonato G; Burra P; Angeli P
Am J Med; 2021 Oct; 134(10):1278-1285.e2. PubMed ID: 34197784
[TBL] [Abstract][Full Text] [Related]
53. Impact of anticoagulation on outcomes in acute non-cirrhotic and non- malignant portal vein thrombosis: a retrospective observational study.
Hall TC; Garcea G; Metcalfe M; Bilk D; Rajesh A; Dennison A
Hepatogastroenterology; 2013; 60(122):311-7. PubMed ID: 23858545
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients.
Han JM; Koh Y; Kim SH; Suh SY; Cho YS; Lee JH; Yu SJ; Yoon JH; Gwak HS
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837493
[No Abstract] [Full Text] [Related]
55. Up to 50% of portal vein thrombosis remains undiagnosed until liver transplantation.
Bert J; Geerts A; Vanlander A; Abreu de Carvalho L; Degroote H; Berrevoet F; Rogiers X; van Vlierberghe H; Verhelst X
Clin Transplant; 2020 Dec; 34(12):e14107. PubMed ID: 33030231
[TBL] [Abstract][Full Text] [Related]
56. [The Effect of Anticoagulant in Patients with Cirrhosis Associated with Acute Portal Vein Thrombosis].
Jo HG; Kim YR; Cho EY
Korean J Gastroenterol; 2021 Sep; 78(3):177-182. PubMed ID: 34565787
[TBL] [Abstract][Full Text] [Related]
57. Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? A Randomized Controlled Trial.
Wang Z; Jiang MS; Zhang HL; Weng NN; Luo XF; Li X; Yang L
Radiology; 2016 Jun; 279(3):943-51. PubMed ID: 26653681
[TBL] [Abstract][Full Text] [Related]
58. Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein thrombosis after splenectomy in cirrhotic portal hypertension.
Yang S; He C; Fan X; Ding W; Wu X; Li J
J Vasc Interv Radiol; 2015 Jul; 26(7):1009-17. PubMed ID: 25921970
[TBL] [Abstract][Full Text] [Related]
59. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.
La Mura V; Tripodi A; Tosetti G; Cavallaro F; Chantarangkul V; Colombo M; Primignani M
Liver Int; 2016 Sep; 36(9):1322-30. PubMed ID: 26854258
[TBL] [Abstract][Full Text] [Related]
60. Portal vein thrombosis after laparoscopic sleeve gastrectomy: presentation and management.
Belnap L; Rodgers GM; Cottam D; Zaveri H; Drury C; Surve A
Surg Obes Relat Dis; 2016 Dec; 12(10):1787-1794. PubMed ID: 27178606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
